Entity Common Stock, Shares Outstanding of REVIVA PHARMACEUTICALS HOLDINGS, INC. from 11 Oct 2018 to 11 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
REVIVA PHARMACEUTICALS HOLDINGS, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 11 Oct 2018 to 11 Nov 2025.
  • REVIVA PHARMACEUTICALS HOLDINGS, INC. Entity Common Stock, Shares Outstanding for the quarter ending 11 Nov 2025 was 115,058,619, a 244% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

REVIVA PHARMACEUTICALS HOLDINGS, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 115,058,619 +81,617,420 +244% 11 Nov 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 68,003,613 +38,186,319 +128% 11 Aug 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 46,739,949 +18,821,389 +67% 14 Mar 2025 10-K 03 Apr 2025 2024 FY
Q3 2024 33,441,199 +10,790,933 +48% 12 Nov 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 29,817,294 +7,167,028 +32% 12 Aug 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 27,918,560 +7,466,439 +37% 31 Mar 2024 10-K 15 Apr 2024 2023 FY
Q3 2023 22,650,266 +2,207,395 +11% 09 Nov 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 22,650,266 +4,516,980 +25% 11 Aug 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 20,452,121 +5,318,835 +35% 27 Mar 2023 10-K 30 Mar 2023 2022 FY
Q3 2022 20,442,871 +6,460,585 +46% 10 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 18,133,286 +4,744,300 +35% 12 Aug 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 15,133,286 +5,901,549 +64% 10 Mar 2022 10-K 15 Mar 2022 2021 FY
Q3 2021 13,982,286 +8,857,855 +173% 12 Nov 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 13,388,986 +8,254,433 +161% 12 Aug 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 9,231,737 +1,562,560 +20% 11 Mar 2021 10-K/A 07 May 2021 2020 FY
Q4 2020 9,231,737 +966,674 +12% 14 Jan 2021 10-Q 14 Jan 2021 2020 Q3
Q3 2020 5,124,431 -3,140,632 -38% 14 Oct 2020 10-Q 14 Oct 2020 2020 Q2
Q2 2020 5,134,553 -3,130,510 -38% 07 Jul 2020 10-Q 07 Jul 2020 2020 Q1
Q1 2020 7,669,177 01 May 2020 10-K 04 May 2020 2020 FY
Q4 2019 8,265,063 0 0% 10 Jan 2020 10-Q 10 Jan 2020 2019 Q3
Q3 2019 8,265,063 0 0% 08 Oct 2019 10-Q 08 Oct 2019 2019 Q2
Q2 2019 8,265,063 03 Jul 2019 10-Q 03 Jul 2019 2020 Q1
Q4 2018 8,265,063 09 Jan 2019 10-Q 09 Jan 2019 2019 Q3
Q3 2018 8,265,063 11 Oct 2018 10-Q 11 Oct 2018 2019 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.